AIGEN INVESTMENT MANAGEMENT, LP - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 189 filers reported holding CARA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
AIGEN INVESTMENT MANAGEMENT, LP ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$155,000
-49.7%
12,604
-11.1%
0.01%
-75.6%
Q1 2021$308,000
-48.7%
14,171
-64.2%
0.04%
-47.4%
Q4 2020$600,000
+32.5%
39,629
+11.2%
0.08%
+34.5%
Q3 2020$453,000
-66.1%
35,637
-54.4%
0.06%
-66.3%
Q2 2020$1,337,00078,1830.17%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders